MPM BioImpact’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,425,202
| Closed | -$5.04M | – | 41 |
|
|
2022
Q2 | $5.04M | Hold |
3,425,202
| – | – | 1.4% | 22 |
|
|
2022
Q1 | $3.94M | Hold |
3,425,202
| – | – | 1.06% | 27 |
|
|
2021
Q4 | $8.56M | Sell |
3,425,202
-547,628
| -14% | -$1.37M | 1.56% | 18 |
|
|
2021
Q3 | $20.3M | Buy |
3,972,830
+1,641,296
| +70% | +$8.4M | 3.16% | 11 |
|
|
2021
Q2 | $19.4M | Hold |
2,331,534
| – | – | 3.18% | 10 |
|
|
2021
Q1 | $20.3M | Hold |
2,331,534
| – | – | 2.55% | 10 |
|
|
2020
Q4 | $25.3M | Sell |
2,331,534
-523,203
| -18% | -$5.68M | 4.45% | 9 |
|
|
2020
Q3 | $34.1M | Buy |
2,854,737
+523,203
| +22% | +$6.24M | 8.21% | 5 |
|
|
2020
Q2 | $37.4M | Hold |
2,331,534
| – | – | 9.96% | 5 |
|
|
2020
Q1 | $36.2M | Hold |
2,331,534
| – | – | 22.09% | 2 |
|
|
2019
Q4 | $57.4M | Buy |
+2,331,534
| New | +$57.4M | 20.33% | 2 |
|